Buccal Cavity Devices Global Market Report 2024

The buccal cavity devices market has grown rapidly in recent years. It will grow from $2.1 billion in 2023 to $2.32 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. During the historic period, the growth observed in this sector can be credited to several factors. Primarily, advancements in oral drug delivery methods played a pivotal role. Additionally, the treatment of chronic conditions, improved patient compliance and convenience, expanding applications in pediatric and geriatric care, and the emergence of localized drug delivery systems contributed significantly to this growth.

The buccal cavity devices market is expected to see strong growth in the next few years. It will grow to $3.33 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. In the forecast period, the anticipated growth stems from several key factors. Expanding therapeutic applications, a heightened focus on precision medicine, the increasing elderly population, advancements in pediatric medication delivery, and a notable preference among patients for non-invasive treatment options are all contributing to this projected growth.

Anticipated escalation in dental disorders is poised to propel the expansion of the buccal cavity devices market. This encompassing term refers to various oral health conditions affecting teeth, gums, and the buccal cavity. The significance of buccal cavity devices in dentistry lies in their role in capturing direct optical impressions and detecting oral health anomalies. The National Health Service's 2022-23 Annual Report from England substantiates this trend, reporting a notable increase in dental disorder treatments from 26.4 million in 2021 to 32.5 million in 2023, marking a substantial 23.2% surge. The upsurge in dental disorders underscores the driving force behind the growth trajectory of the buccal cavity devices market.

The burgeoning geriatric demographic, typically aged 65 and above, is expected to significantly contribute to the burgeoning buccal cavity devices market. Elderly individuals are notably more susceptible to various oral ailments, necessitating specialized treatments, wherein buccal cavity devices play a pivotal role. Notably, projections from the World Health Organization indicate a profound demographic shift. By 2030, an estimated one-sixth of the global population will be aged 60 or older, escalating from 1 billion in 2020 to 1.4 billion. Moreover, by 2050, this demographic is set to double, reaching 2.1 billion. This surge, including a projected 426 million individuals aged 80 or older by 2050, underscores the substantial influence of the growing geriatric population on propelling the buccal cavity devices market.

Technological evolution stands as a pivotal trend shaping the landscape of buccal cavity devices. Leading entities within this sector are focused on developing advanced products to fortify their market standing. A notable example includes 3Shape, a Denmark-based digital dental solutions provider, launching TRIOS 5 Wireless in September 2022. This state-of-the-art intraoral scanner, equipped with Scan Assist intelligent alignment technology, ensures seamless and expedited intraoral scanning. Enhanced with an LED ring and tactile feedback, TRIOS 5 Wireless streamlines the scanning process, minimizing misalignments and distortions in 3D models. This emphasis on technological innovation reflects companies' strategic pursuit to deliver enhanced products within the buccal cavity devices market.

Strategic collaborations amongst key players in the buccal cavity devices sector are pivotal for driving market expansion and profitability. These partnerships are instrumental in developing and commercializing innovative solutions catering to diverse oral health issues. For instance, in March 2023, EVERSANA, a US-based life sciences service provider, partnered with ChemoMouthpiece LLC, an oncology supportive care company, to facilitate the launch and commercialization of the Chemo Mouthpiece. This buccal cavity device offers oral cryotherapy for chemotherapy-induced oral mucositis. EVERSANA's comprehensive suite of services, encompassing market access, regulatory compliance, patient services, data analytics, and distribution solutions, underscores the pivotal role of strategic collaborations in bringing specialized buccal cavity devices to market and addressing critical healthcare needs.

In December 2022, Alleima Ltd., a Sweden-based manufacturer of high-value-added products, acquired Endosmart Gesellschaft für Medizintechnik GmbH for an undisclosed amount. The acquisition of Endosmart strengthens and expands Alleima's position in the medical segment and product portfolio offerings. Endosmart Gesellschaft für Medizintechnik GmbH is a Germany-based manufacturer of medical devices and components, including dental cavity and intraoral cameras.

Major companies operating in the buccal cavity devices market report are Carestream Health Inc., Denstply Sirona Inc., Denterprise International Inc., Detection Technology plc, FONA Dental srl, Hamamatsu Corporation, Trixell SAS, Varex Imaging Corporation, Cyber Medical Imaging Inc., The Yoshida Dental Mfg Co. Ltd., Acteon Group Ltd., Align Technology Inc., Midmark Corporation, Planmeca Group, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, AstraZeneca plc, Merck & Co. Inc., Pfizer Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sanofi S.A., 3M Company, Colgate-Palmolive Company, Procter & Gamble Co., Cipla Ltd., Abbott Laboratories, Bausch Health Companies Inc., Mylan N.V.

North America was the largest region in the buccal cavity devices market in 2023. The regions covered in the buccal cavity devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the buccal cavity devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

These devices encompass various product types, including intraoral scanners, intraoral x-ray tubing, intraoral cameras, and others. Intraoral scanners, electronic devices capturing digital scans of intraoral structures, serve diverse purposes such as diagnostics, therapeutics, and more. These devices find application across dental clinics, hospitals, and similar medical settings.

The buccal cavity devices market research report provides buccal cavity devices market statistics, including buccal cavity devices industry global market size, regional shares, competitors with a buccal cavity devices market share, detailed buccal cavity devices market segments, market trends and opportunities, and any further data you may need to thrive in the buccal cavity devices industry. This buccal cavity devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal cavity devices market consists of sales of dental mirrors, probes and explorers, dental forceps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.